Editorial Article
Unlocking the potential of the multi-attribute method (MAM): The future of biopharma
New eBooks by Waters Corporation reveal the capabilities, adoption trends, and future of MAM for biotherapeutic analysis
New eBooks by Waters Corporation reveal the capabilities, adoption trends, and future of MAM for biotherapeutic analysis
CrestOptics lauches CICERO: The cost effective solution for widefield and confocal imaging
New HPLC refractive index detector from Biotech Fluidics
Fujirebio adds another two markers to its fully automated blood-based biomarker portfolio